149 related articles for article (PubMed ID: 17101596)
21. Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma.
Alhamarneh O; Agada F; Madden L; Stafford N; Greenman J
Head Neck; 2011 Mar; 33(3):415-23. PubMed ID: 20645289
[TBL] [Abstract][Full Text] [Related]
22. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
23. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
[TBL] [Abstract][Full Text] [Related]
24. HER2 expression predicts improved survival in patients with cervical node-positive head and neck squamous cell carcinoma.
Tse GM; Yu KH; Chan AW; King AD; Chen GG; Wong KT; Tsang RK; Chan AB
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):467-73. PubMed ID: 19786214
[TBL] [Abstract][Full Text] [Related]
25. Assessment of lymphocyte proliferation: CFSE kills dividing cells and modulates expression of activation markers.
Last'ovicka J; Budinský V; Spísek R; Bartůnková J
Cell Immunol; 2009; 256(1-2):79-85. PubMed ID: 19233349
[TBL] [Abstract][Full Text] [Related]
26. Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2.
Janke M; Peeters B; Zhao H; de Leeuw O; Moorman R; Arnold A; Ziouta Y; Fournier P; Schirrmacher V
Int J Oncol; 2008 Oct; 33(4):823-32. PubMed ID: 18813797
[TBL] [Abstract][Full Text] [Related]
27. [The T cell activation from peripheral blood of patients with herpetic keratitis following in vitro activation].
Liu Z; Chen J; Li S; Zeng Y; Sun H
Yan Ke Xue Bao; 1999 Dec; 15(4):225-8. PubMed ID: 12579674
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN
Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030
[TBL] [Abstract][Full Text] [Related]
29. Soluble CD44 is a potential marker for the early detection of head and neck cancer.
Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000
[TBL] [Abstract][Full Text] [Related]
30. Detection of micrometastatic tumor cells in head and neck squamous cell carcinoma. A possible predictor of recurrences?
Guney K; Yoldas B; Ozbilim G; Derin AT; Sarihan S; Balkan E
Saudi Med J; 2007 Feb; 28(2):216-20. PubMed ID: 17268699
[TBL] [Abstract][Full Text] [Related]
31. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
Scher RL
Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613
[TBL] [Abstract][Full Text] [Related]
32. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
[TBL] [Abstract][Full Text] [Related]
33. [Selected markers of T cell activation in children with idiopathic uveitis].
Bakunowicz-Łazarczyk A; Moniuszko T; Sredzińska-Kita D; Mrugacz M
Klin Oczna; 2001; 103(4-6):191-3. PubMed ID: 11975016
[TBL] [Abstract][Full Text] [Related]
34. Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis.
Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
Acta Otolaryngol; 1999 Mar; 119(2):281-4. PubMed ID: 10320092
[TBL] [Abstract][Full Text] [Related]
35. Expression of IL-10 and IL-10 receptors on peripheral blood lymphocytes and monocytes in human head and neck squamous cell carcinoma.
Kato H; Whiteside TL
Tokai J Exp Clin Med; 2011 Dec; 36(4):144-51. PubMed ID: 22167499
[TBL] [Abstract][Full Text] [Related]
36. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma.
Tse GM; Chan AW; Yu KH; King AD; Wong KT; Chen GG; Tsang RK; Chan AB
Ann Surg Oncol; 2007 Dec; 14(12):3558-65. PubMed ID: 17929099
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotype of peripheral T lymphocytes, NK cells and expression of CD69 activation marker in patients with recurrent spontaneous abortions, during the mid-luteal phase.
Prado-Drayer A; Teppa J; Sánchez P; Camejo MI
Am J Reprod Immunol; 2008 Jul; 60(1):66-74. PubMed ID: 18593439
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
39. Toll-like Receptors in Regulatory T Cells of Patients With Head and Neck Cancer.
Wild CA; Brandau S; Lindemann M; Lotfi R; Hoffmann TK; Lang S; Bergmann C
Arch Otolaryngol Head Neck Surg; 2010 Dec; 136(12):1253-9. PubMed ID: 21173376
[TBL] [Abstract][Full Text] [Related]
40. T-cell activation in patients with irritable bowel syndrome.
Ohman L; Isaksson S; Lindmark AC; Posserud I; Stotzer PO; Strid H; Sjövall H; Simrén M
Am J Gastroenterol; 2009 May; 104(5):1205-12. PubMed ID: 19367268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
